press release: NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil®... -- CHICAGO, June 5, 2011 /PRNewswire/ --
Ovarian Cancer and Us
OVARIAN CANCER and US
Ovarian Cancer and Us
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.